Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Steyn

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
ACS Medicinal Chemistry Letters|May 26, 2015
Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic StabilityMartin Pettersson, Douglas S Johnson, John M Humphrey, et al.
Mabs|September 26, 2012
Biochemical and pharmacological characterization of human c-Met neutralizing monoclonal antibody CE-355621Neil R Michaud, Jitesh P Jani, Stephen Hillerman, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2023
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6<sup>+</sup> T Cells, and Ameliorates Interleukin-23-Induced Skin InflammationWei Li, Kimberly K Crouse, Jennifer Alley, et al.
Journal of Medicinal Chemistry|June 9, 2016
Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side EffectsJennifer E Davoren, Che-Wah Lee, Michelle Garnsey, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 27, 2016
17α-Estradiol Alleviates Age-related Metabolic and Inflammatory Dysfunction in Male Mice Without Inducing FeminizationMichael B Stout, Frederik J Steyn, Michael J Jurczak, et al.
European Journal of Human Genetics : EJHG|April 28, 2021
Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophreniaRestuadi Restuadi, Fleur C Garton, Beben Benyamin, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2019
IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory HyperfunctionSjoerd D Joustra, Ferdinand Roelfsema, A S Paul van Trotsenburg, et al.
Genome Medicine|January 19, 2022
Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1Restuadi Restuadi, Frederik J Steyn, Edor Kabashi, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2013
Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptorKim F McClure, Margaret Jackson, Kimberly O Cameron, et al.
Cell Reports|October 28, 2020
Genome-wide Meta-analysis Finds the ACSL5-ZDHHC6 Locus Is Associated with ALS and Links Weight Loss to the Disease GeneticsAlfredo Iacoangeli, Tian Lin, Ahmad Al Khleifat, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
ACS Medicinal Chemistry Letters|May 26, 2015
Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic StabilityMartin Pettersson, Douglas S Johnson, John M Humphrey, et al.
Mabs|September 26, 2012
Biochemical and pharmacological characterization of human c-Met neutralizing monoclonal antibody CE-355621Neil R Michaud, Jitesh P Jani, Stephen Hillerman, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2023
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6<sup>+</sup> T Cells, and Ameliorates Interleukin-23-Induced Skin InflammationWei Li, Kimberly K Crouse, Jennifer Alley, et al.
Journal of Medicinal Chemistry|June 9, 2016
Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side EffectsJennifer E Davoren, Che-Wah Lee, Michelle Garnsey, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 27, 2016
17α-Estradiol Alleviates Age-related Metabolic and Inflammatory Dysfunction in Male Mice Without Inducing FeminizationMichael B Stout, Frederik J Steyn, Michael J Jurczak, et al.
European Journal of Human Genetics : EJHG|April 28, 2021
Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophreniaRestuadi Restuadi, Fleur C Garton, Beben Benyamin, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2019
IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory HyperfunctionSjoerd D Joustra, Ferdinand Roelfsema, A S Paul van Trotsenburg, et al.
Genome Medicine|January 19, 2022
Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1Restuadi Restuadi, Frederik J Steyn, Edor Kabashi, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2013
Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptorKim F McClure, Margaret Jackson, Kimberly O Cameron, et al.
Cell Reports|October 28, 2020
Genome-wide Meta-analysis Finds the ACSL5-ZDHHC6 Locus Is Associated with ALS and Links Weight Loss to the Disease GeneticsAlfredo Iacoangeli, Tian Lin, Ahmad Al Khleifat, et al.
Pageof 17